Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Bowden
C L
CL
Department of Psychiatry, University of Texas Health Science Center, San Antonio, USA.
D000927:Anticonvulsants / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology; D002220:Carbamazepine / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D001523:Mental Disorders / Q000188:drug therapy* / Q000517:prevention & control / Q000523:psychology; D019964:Mood Disorders / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology; D014635:Valproic Acid
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D002220:Carbamazepine; D014635:Valproic Acid; D008094:Lithium